JP2003502270A - ２１−ヒドロキシ−６，１９−オキシドプロゲステロン（２１ｏｈ−６ｏｐ）、及びそれのグルココルチコイド過剰を治療する薬剤としての使用 - Google Patents
２１−ヒドロキシ−６，１９−オキシドプロゲステロン（２１ｏｈ−６ｏｐ）、及びそれのグルココルチコイド過剰を治療する薬剤としての使用Info
- Publication number
- JP2003502270A JP2003502270A JP2000512550A JP2000512550A JP2003502270A JP 2003502270 A JP2003502270 A JP 2003502270A JP 2000512550 A JP2000512550 A JP 2000512550A JP 2000512550 A JP2000512550 A JP 2000512550A JP 2003502270 A JP2003502270 A JP 2003502270A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- glucocorticoid
- steroid
- cushing
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1998/006021 WO1999015181A1 (en) | 1997-09-23 | 1998-09-22 | 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003502270A true JP2003502270A (ja) | 2003-01-21 |
| JP2003502270A5 JP2003502270A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=8167069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000512550A Withdrawn JP2003502270A (ja) | 1998-09-22 | 1998-09-22 | ２１−ヒドロキシ−６，１９−オキシドプロゲステロン（２１ｏｈ−６ｏｐ）、及びそれのグルココルチコイド過剰を治療する薬剤としての使用 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003502270A (cg-RX-API-DMAC7.html) |
-
1998
- 1998-09-22 JP JP2000512550A patent/JP2003502270A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69804659T2 (de) | 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss | |
| DE60216630T2 (de) | Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie | |
| AU2009201956B2 (en) | Pregnane steroids for use in the treatment of CNS disorders | |
| DE69034148T2 (de) | Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie | |
| RU2137476C1 (ru) | Применение конкурентных антагонистов прогестерона для контрацепции, новые соединения ряда конкурентных антагонистов прогестерона | |
| JP2656958B2 (ja) | ホルモン依存性腫瘍治療剤 | |
| EP3335043B1 (en) | Method for differentially diagnosing acth-dependent cushing's syndrome | |
| JP2002541126A (ja) | 低用量エストロゲン断続的ホルモン補充療法 | |
| DE3590389T1 (de) | Pharmazeutische Zusammensetzung für eine Kombinationstherapie hormon-abhängiger Cancer | |
| JP2002505334A (ja) | アゴニスト又はアンタゴニストホルモン特性を有する２０−ケト−１１β−アリールステロイドとその誘導体 | |
| ME01122B (me) | Jedinjenja i postupci za liječenje raka dojke | |
| KR20090067198A (ko) | 자궁내막 증식을 억제하는 조성물과 방법 | |
| Sutanto et al. | Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects | |
| JP2005526032A (ja) | エストロゲンレセプターβを選択的に調節する植物性エストロゲン含有抽出物の利用法 | |
| JPS60161998A (ja) | １α，２α―メチレン―６―メチレン―又は―６α―メチル―プレグネン及びその製法 | |
| EP1812009B1 (en) | Gaba-steroid antagonists and their use for the treatment of cns disorders | |
| WO2004112797A1 (en) | Hormone replacement- and depression therapy comprising dienogest | |
| JPH11507050A (ja) | 前立腺病の処置および予防 | |
| EP0399631B1 (en) | Use of gestodene for the production of pharmaceutical agents | |
| US5652231A (en) | Carcinostatic for hormonotherapy containing dienogest as effective component | |
| Sobel | Progestins in preventive hormone therapy: including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages? | |
| Sander et al. | On gestagen treatment of advanced prostatic carcinoma | |
| Sorbera et al. | Trimegestone | |
| Bardin et al. | New York, New York | |
| DE10134768A1 (de) | Pharmazeutische Kombinationspräparate enthaltend Aromatasehemmer und Substanzen mit estrogener Wirkung sowie ihre Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050722 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050722 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20080625 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20090513 |